The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Genetic profiling of advanced RAI-resistant differentiated thyroid cancer and correlation with axitinib response.
Rebecca B. Schechter
No relevant relationships to disclose
Madhavi Nagilla
No relevant relationships to disclose
Loren Joseph
No relevant relationships to disclose
Poluru L. Reddy
No relevant relationships to disclose
Arun Khattri
No relevant relationships to disclose
Sydeaka Watson
No relevant relationships to disclose
Laura D. Locati
No relevant relationships to disclose
Lisa F. Licitra
Consultant or Advisory Role - Amgen; Boehringer Ingelheim; Bristol-Myers Squibb; GlaxoSmithKline; Lilly; Merck Serono; Pfizer
Angela Greco
No relevant relationships to disclose
Giuseppe Pelosi
No relevant relationships to disclose
Maria Luisa Carcangiu
No relevant relationships to disclose
Tanguy Y. Seiwert
Consultant or Advisory Role - Boehringer Ingelheim
Honoraria - Boehringer Ingelheim
Research Funding - Boehringer Ingelheim
Ezra E.W. Cohen
Consultant or Advisory Role - Boehringer Ingelheim
Honoraria - Biodesix